Over 460 million people worldwide have diabetes, and 90% of them have type II diabetes. While there are many treatments available, a lot of people are prescribed liraglutide marketed by Novo Nordisk as Saxenda and Victoza.
When administered, liraglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, a natural hormone that regulates blood sugar levels. Liraglutide also helps reduce the risks of cardiovascular problems. In recent years, GLP-1 medications have also been marketed as a means for people to lose weight easily, making them more popular than ever.
Liraglutide’s most common side effects include nausea, vomiting, diarrhea, decreased appetite, fatigue, headaches, and injection site reactions in some cases. Of these side effects, nausea is the most common, but studies show that this becomes less likely over time. Unfortunately, these aren’t the only side effects you can experience from liraglutide.
In recent years, it’s come to light that GLP-1 RA medications like liraglutide also result in serious conditions. If you’re suffering from any of these, you might be eligible to file a claim:
Liraglutide is the active ingredient of the following:
If you’ve been diagnosed with type 2 diabetes and are seeking treatment, there’s a chance that you’ve taken liraglutide before. Have you been experiencing serious health conditions caused by medications like Saxenda or Victoza? If you have, we encourage you to reach out to our team. Start by considering the following criteria:
You can also reach out to us to see if you are eligible to file a liraglutide claim if you experienced persistent vomiting (4 weeks or more) with hospitalization or ER visits while taking the drug or within 60 days of stopping and if you were hospitalized for any gastric issue while using liraglutide.
There has been an influx of lawsuits against GLP-1 receptor agonists in the last couple of years. Just in February 2025, the US Judicial Panel on Multidistrict Litigation compiled these lawsuits into MDL 3094, which currently has over 1,300 lawsuits for liraglutide, semaglutide, and dulaglutide.
In June 2024, a woman from Kentucky took Novo Nordisk to court. She argued that the company didn’t adequately highlight the serious medical conditions that could be caused by liraglutide, citing gastroparesis specifically. As per her records, the woman underwent liraglutide treatment from March 2019 to April 2021. Her gastroparesis has resulted in constant abdominal pain, as well as vomiting, that required medical attention.
Gastroparesis and other severe medical conditions caused by liraglutide and other GLP-1 RAs can cause a lifetime of problems. If you or your relative are suffering from these health problems, we’re encouraging you to reach out to our team. We’ll assess your situation and see if you’re eligible for financial compensation. Once we see a strong case, we’ll refer you to an attorney who specializes in liraglutide claims.
10 Minutes Over the Phone
*No fees unless compensation is obtained
